Showing results (231-240 of 286) with videos related to
Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)Jennifer H Foster, Stephan D Voss, David C Hall, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Recommendations for the return of research results to study participants and guardians: a report from the Children's Oncology GroupConrad V Fernandez, Kathleen Ruccione, Robert J Wells, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium reportMaryam Fouladi, Julie R Park, Clinton F Stewart, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report, Maryam Fouladi, Wayne L Furman, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|September 30, 2022
Mortality Risk in Pediatric Sepsis Based on C-reactive Protein and Ferritin LevelsChristopher M Horvat, Anthony Fabio, Daniel S Nagin, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|September 21, 2023
Viral Detection by Reverse Transcriptase Polymerase Chain Reaction in Upper Respiratory Tract and Metagenomic RNA Sequencing in Lower Respiratory Tract in Critically Ill Children With Suspected Lower Respiratory Tract InfectionChristina M Osborne, Charles Langelier, Jack Kamm, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumorsElizabeth Fox, Richard Aplenc, Rochelle Bagatell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Intrathecal mafosfamide: a preclinical pharmacology and phase I trialSusan M Blaney, Frank M Balis, Stacey Berg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group StudyNajat C Daw, Wayne L Furman, Clinton F Stewart, et al.Pediatric Blood & Cancer|March 4, 2015
Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.Pageof 29